IL101627A0 - 4-aryl-3-(heteroarylureido)quinoline derivatives - Google Patents

4-aryl-3-(heteroarylureido)quinoline derivatives

Info

Publication number
IL101627A0
IL101627A0 IL101627A IL10162792A IL101627A0 IL 101627 A0 IL101627 A0 IL 101627A0 IL 101627 A IL101627 A IL 101627A IL 10162792 A IL10162792 A IL 10162792A IL 101627 A0 IL101627 A0 IL 101627A0
Authority
IL
Israel
Prior art keywords
heteroarylureido
aryl
quinoline derivatives
quinoline
derivatives
Prior art date
Application number
IL101627A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL101627A0 publication Critical patent/IL101627A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
IL101627A 1991-04-26 1992-04-16 4-aryl-3-(heteroarylureido)quinoline derivatives IL101627A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69232391A 1991-04-26 1991-04-26

Publications (1)

Publication Number Publication Date
IL101627A0 true IL101627A0 (en) 1992-12-30

Family

ID=24780107

Family Applications (1)

Application Number Title Priority Date Filing Date
IL101627A IL101627A0 (en) 1991-04-26 1992-04-16 4-aryl-3-(heteroarylureido)quinoline derivatives

Country Status (20)

Country Link
EP (1) EP0590094A1 (es)
JP (1) JPH0776215B2 (es)
CN (1) CN1066068A (es)
AU (1) AU1879792A (es)
BR (1) BR9205939A (es)
CA (1) CA2108014A1 (es)
CZ (1) CZ395592A3 (es)
DE (1) DE9290049U1 (es)
FI (1) FI934710A0 (es)
HU (1) HUT65748A (es)
IE (1) IE921330A1 (es)
IL (1) IL101627A0 (es)
MX (1) MX9201916A (es)
NO (1) NO933837L (es)
NZ (1) NZ242493A (es)
PT (1) PT100426A (es)
TW (1) TW197436B (es)
WO (1) WO1992019614A1 (es)
YU (1) YU44592A (es)
ZA (1) ZA922976B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE175196T1 (de) * 1992-01-23 1999-01-15 Pfizer 4-phenyl-3-(heteroarylureido)-1,2-dihydro-2- oxochinolin derivate, als antihypercholesterolemische und antiatherosklerotische mittel
US5565472A (en) * 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5843957A (en) * 1995-05-19 1998-12-01 Sumitomo Pharmaceuticals Company, Ltd. Naphthyridine derivatives
CA2222687A1 (en) * 1995-05-31 1996-12-05 Masami Muraoka Novel naphthyridine derivatives
KR20000057268A (ko) * 1996-11-26 2000-09-15 다께우찌 마사야쓰 나프티리딘 유도체
US6452008B2 (en) 1998-02-25 2002-09-17 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for preparing the same
WO1999043659A1 (fr) 1998-02-25 1999-09-02 Sumitomo Pharmaceuticals Co., Ltd. Derives de pyridone et leur procede de fabrication
BRPI0417543A (pt) * 2003-12-12 2007-03-27 Wyeth Corp quinolinas úteis no tratamento de doença cardiovascular
CN103601677B (zh) * 2013-11-19 2015-11-18 清华大学 制备2-烷硫基喹啉衍生物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE892088L (en) * 1988-07-12 1990-01-12 William Henry Deryk Morris Quinoline derivatives, their production and use
MX22406A (es) * 1989-09-15 1994-01-31 Pfizer Nuevos derivados de n-aril y n-heteroarilamidas y urea como inhibidores de acil coenzima a: acil transferasa del colesterol (acat).
TW205037B (es) * 1989-10-06 1993-05-01 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
CA2108014A1 (en) 1992-10-27
EP0590094A1 (en) 1994-04-06
JPH0776215B2 (ja) 1995-08-16
MX9201916A (es) 1992-11-01
AU1879792A (en) 1992-12-21
IE921330A1 (en) 1992-11-04
CN1066068A (zh) 1992-11-11
PT100426A (pt) 1993-08-31
FI934710A (fi) 1993-10-25
NO933837L (no) 1993-10-25
CZ395592A3 (en) 1994-02-16
FI934710A0 (fi) 1993-10-25
ZA922976B (en) 1993-10-25
JPH06501025A (ja) 1994-01-27
YU44592A (sh) 1994-12-28
BR9205939A (pt) 1994-09-27
HUT65748A (en) 1994-07-28
HU9303025D0 (en) 1994-01-28
NZ242493A (en) 1994-08-26
TW197436B (es) 1993-01-01
DE9290049U1 (de) 1994-01-05
WO1992019614A1 (en) 1992-11-12

Similar Documents

Publication Publication Date Title
GB9108547D0 (en) Quinoline derivatives
GR3023621T3 (en) 3-Hydroxy-4-aryl-5-oxo-pyrazolin derivatives
SG44523A1 (en) Quinoline derivatives
HU9300545D0 (en) Sulfobenzyil-substituted pyridone derivatives
HU9203994D0 (en) Imidazo-pyridine derivatives
GB8827820D0 (en) (1h-azol-1-ylmethyl)substituted quinoline derivatives
GB8827822D0 (en) (1h-azol-1-ylmethyl)substituted quinoline derivatives
HU9202768D0 (en) Cyano-phenyl-pyrrole derivatives
EP0438690A3 (en) Substituted pyrazolin derivatives
EP0467325A3 (en) Carbostyril derivatives
IL101627A0 (en) 4-aryl-3-(heteroarylureido)quinoline derivatives
HU9202388D0 (en) Aryl-alkyl-amine derivatives
ZA92278B (en) 3-quinuclidine derivatives
EP0520435A3 (en) Dc-89 derivatives
GB9126438D0 (en) New quinoline derivatives
HU9200011D0 (en) Trifluoro-methyl-1-carba(1-dethia)-cepheme derivatives
GB2262739B (en) Benzofuranylimidazole derivatives
ZA92786B (en) Pyrimidinyl-and triazinylsalicyl-and-picolinylaldehyde derivatives
HU9200105D0 (en) Bipiridyl derivatives
ZA92183B (en) Acridine derivatives
IE901869L (en) Quinoline derivatives
GB9201427D0 (en) Quinoline derivatives
LTIP1942A (en) Quinoline derivatives
IE900817L (en) Tetrahydroquinoline derivatives
GB9106070D0 (en) Benzodioxanylimidazole derivatives